Nature of the postsynaptic action of crotoxin at guinea-pig diaphragm end-plates

O V Brazil1, M D Fontana, N F Heluany

  • 1Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas (UNICAMP), SP, Brazil.

Journal of Natural Toxins
|March 4, 2000
PubMed

Insights

Crotoxin causes blockade at mammalian muscle end-plates by desensitizing nicotinic receptors. This effect is reversed by 4-aminopyridine (4-AP), confirming a receptor desensitization mechanism, not a curaremimetic action.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Toxicology

Background:

  • Crotoxin is a neurotoxin known to affect nicotinic receptors in non-mammalian species.
  • The mechanism of crotoxin's action at mammalian neuromuscular junctions remains unclear.

Purpose of the Study:

  • To determine if crotoxin's postsynaptic effect at mammalian muscle end-plates is due to receptor desensitization or a curaremimetic action.
  • To investigate the role of 4-aminopyridine (4-AP) in modulating crotoxin's effects.

Main Methods:

  • Experiments were conducted on guinea-pig diaphragms.
  • Miniature end-plate potentials (m.e.p.p.s) and carbachol-induced end-plate depolarization were measured.
  • The effects of crotoxin, 4-aminopyridine (4-AP), neostigmine, d-tubocurarine (dTc), and beta-bungarotoxin (beta-BTX) were assessed.

Main Results:

  • Crotoxin blocked m.e.p.p.s at low concentrations, an effect antagonized by 4-AP.
  • 4-AP did not restore m.e.p.p.s blocked by dTc or beta-BTX.
  • Crotoxin-induced blockade of carbachol-evoked depolarization was also antagonized by 4-AP.

Conclusions:

  • The postsynaptic effect of crotoxin at the guinea-pig muscle end-plate is caused by nicotinic receptor desensitization.
  • 4-aminopyridine (4-AP) acts as an antagonist to this crotoxin-induced receptor desensitization.

Related Concept Videos

G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Cholinergic Receptors: Nicotinic01:15

Cholinergic Receptors: Nicotinic

Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...